BioSpace News Archive

Press Releases

Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers

September 9, 2026
·
9 min read
Press Releases

NaNotics Study Demonstrates New Nanotechnology Approach to Cancer Immunotherapy

September 9, 2026
·
5 min read
Press Releases

Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs

September 9, 2026
·
6 min read
Press Releases

Latus Bio Appoints Donald Hayden as Chairman of the Board and Michael MacLean as Independent Director and Audit Committee Chair

September 9, 2026
·
4 min read
Press Releases

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

September 9, 2026
·
5 min read
Press Releases

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

September 9, 2026
·
8 min read
Press Releases

NervGen to Host Inaugural R&D Day on September 30, 2026

September 9, 2026
·
5 min read
Press Releases

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

September 9, 2026
·
4 min read
Press Releases

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

September 9, 2026
·
10 min read
Press Releases

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference

September 9, 2026
·
4 min read